Search - tctmd.com

Displaying 921 - 940 of 1179

Sort: Relevancy | Date

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

October 18, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

News Daily News

El Apixaban tiene el Mismo Riesgo Hemorrágico que la Aspirina en Pacientes con FA

L.A. McKeown

October 10, 2012

News Daily News

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

L.A. McKeown

October 10, 2012

Presentation

Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial

Presenter: Greg C. Flaker

October 09, 2012

News Daily News

Post-PCI Stress Testing Trends Downward

October 09, 2012

News Daily News

JACC Viewpoint: Studies Needed on Long-term Consequences of ‘Silent’ Cerebral Infarcts

L.A. McKeown

October 03, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

News Daily News

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

September 20, 2012

Presentation

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Presenter: B-K Kim

September 19, 2012

Presentation

Double Antiplatelet Therapy After DES Implantation

Presenter: I. Ferreira-Gonz?lez

September 19, 2012

News Daily News

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

L.A. McKeown

September 18, 2012

News Daily News

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

L.A. McKeown

September 18, 2012

News Daily News

Early Invasive Strategy in NSTEMI Patients Improves Survival

September 18, 2012

News Daily News

Dabigatran Usage up, Both for A-fib and Off-Label Indications

September 12, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

Presentation ESC 2012

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Presenter: Willem Dewilde

August 28, 2012

Advertisement

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Study Supports Half-Dose Prasugrel for Low-Weight CAD Patients

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

El Apixaban tiene el Mismo Riesgo Hemorrágico que la Aspirina en Pacientes con FA

Apixaban Matches Bleeding Risk of Aspirin in A-fib Patients

Bleeding with Aspirin vs. Apixaban in Patients with A-fib Unsuitable for Warfarin: The AVERROES Trial

Post-PCI Stress Testing Trends Downward

JACC Viewpoint: Studies Needed on Long-term Consequences of ‘Silent’ Cerebral Infarcts

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

Studies Suggest Less Stringent Dual Antiplatelet Use After DES

RESET Trial: A New Strategy for Discontinuation of Dual Antiplatelet Therapy

Double Antiplatelet Therapy After DES Implantation

La Dosis de Carga Doble de Clopidogrel No Ofrece Beneficio Alguno en Pacientes con ERC que se someten a PCI Primarias

Double Clopidogrel Loading Dose Offers No Benefit in Primary PCI Patients with CKD

Early Invasive Strategy in NSTEMI Patients Improves Survival

Dabigatran Usage up, Both for A-fib and Off-Label Indications

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content